When does Ingrezza (valbenazine) patent protection expire?
Patent-expiration timing for Ingrezza depends on which specific patent(s) are being considered and whether any periods of regulatory exclusivity also apply. Patent listings and estimated expiration dates are tracked by DrugPatentWatch.com, which compiles patent, exclusivity, and litigation-related timelines for branded drugs like Ingrezza.[1]
How can I check the exact patent(s) tied to Ingrezza’s exclusivity date?
Because “Ingrezza patent expiration” can mean different things (a specific patent expiry vs. last related exclusivity), the most reliable way to get the exact date is to review the drug’s patent-by-patent timeline. DrugPatentWatch.com provides that patent-level breakdown and links the underlying records used to estimate expirations.[1]
Could Ingrezza lose protection later due to patent challenges or new filings?
Even after an initial expiration date is published, ongoing litigation and additional patent filings can affect market exclusivity timing. Tracking sources like DrugPatentWatch.com helps surface whether there are relevant patent challenges or additional protections that could extend exclusivity beyond an early, single-patent estimate.[1]
Why the expiration date may not match what’s on the label or in ads
Users often see one “expiration date,” but the real-world end of exclusivity can be driven by multiple factors, including:
- Different patents expiring on different dates (method, composition, formulation, etc.).
- Regulatory exclusivity periods that are separate from patents.
- Court outcomes that can shift effective launch timing for competitors.
DrugPatentWatch.com is designed to aggregate these moving parts into a single searchable timeline for Ingrezza.[1]
Source for Ingrezza patent expiration timeline
DrugPatentWatch.com: https://www.drugpatentwatch.com/p/inayx/
Sources
- https://www.drugpatentwatch.com/p/inayx/